Medline Inc. faced a significant stock price drop after the FDA issued a warning for serious violations in its pharmaceutical manufacturing practices, including failure to investigate discrepancies and microbial contamination. The stock fell over 7% following the FDA letter and dropped further by 12% after disappointing Q2 results and lowered full-year earnings guidance. Investors who suffered losses may have legal rights under federal securities laws, with a law firm investigating potential claims.
Whale wallets have accumulated about 1.54 billion XRP tokens worth $2.2 billion in 96 hours, signaling strong investor confidence as XRP trades near $1.41. This large-scale buying reduces XRP's circulating supply, potentially supporting higher prices...
BlackRock reports Bitcoin volatility has dropped from about 80 to 35-40, driven by ETFs, options, deeper liquidity, and long-term holders. Large Bitcoin holders increasingly use Bitcoin ETFs like BlackRock's IBIT to access collateralized borrowing, h...
The SEC's new five-year Innovation Exemption allows trading of tokenized U.S. stocks on public blockchains with shareholder rights equal to traditional shares. This framework could open new revenue streams for companies like Coinbase, Robinhood, and ...
Solana (SOL) is showing strong momentum in October, leading large-cap altcoins with a 9% weekly gain and breaking key resistance levels. Its relative demand is increasing compared to Ethereum and Bitcoin, supported by fresh institutional inflows into...
XRP has surpassed the $1.40 mark, signaling renewed investor interest as the XRP Ledger (XRPL) broadens its financial ecosystem beyond payments. The recent XRPL 3.4.0 upgrade introduced a lending framework supporting fixed-term, uncollateralized loan...
